{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:10:14Z","timestamp":1782411014094,"version":"3.54.5"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:00:00Z","timestamp":1794700800000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P30NS076408"],"award-info":[{"award-number":["P30NS076408"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P41EB027061"],"award-info":[{"award-number":["P41EB027061"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006010","name":"Bayer Schering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023368","name":"Eisai Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019139","name":"Life Sciences, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["U01-AG016976"],"award-info":[{"award-number":["U01-AG016976"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["UF1-AG32438"],"award-info":[{"award-number":["UF1-AG32438"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["U19-AG24904"],"award-info":[{"award-number":["U19-AG24904"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["RF1-AG57547"],"award-info":[{"award-number":["RF1-AG57547"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 NS100620"],"award-info":[{"award-number":["U01 NS100620"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS124065"],"award-info":[{"award-number":["R01NS124065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG006786"],"award-info":[{"award-number":["U01 AG006786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG062677"],"award-info":[{"award-number":["P30 AG062677"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG034676"],"award-info":[{"award-number":["R01 AG034676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS080816"],"award-info":[{"award-number":["R01 NS080816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AG16574"],"award-info":[{"award-number":["P50 AG16574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["C06 RR018898"],"award-info":[{"award-number":["C06 RR018898"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG011378"],"award-info":[{"award-number":["R01 AG011378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG041851"],"award-info":[{"award-number":["R01 AG041851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS097495"],"award-info":[{"award-number":["R01 NS097495"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neurobiolaging.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:55:07Z","timestamp":1762833307000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["1H-MR spectroscopy biomarkers are associated with plasma-derived biomarkers of amyloid-\u03b2 and tau in the early phase of AD continuum"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4679-8110","authenticated-orcid":false,"given":"Firat","family":"Kara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Joers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Przybelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclin","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejal","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.11.003_bib1","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib2","series-title":"Magnetic Resonance Spectroscopy","first-page":"122","article-title":"Other significant metabolites: myo-inositol, gaba, glutamine, and lactate","author":"Best","year":"2014"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.11.003_bib3","first-page":"1619","article-title":"Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy","volume":"20","author":"Bitsch","year":"1999","journal-title":"Ajnr. Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-120778","article-title":"Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions","volume":"36","author":"Bittner","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"3-5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000111347","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells","volume":"15","author":"Brand","year":"1994","journal-title":"Dev. Neurosci."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.11.003_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/cercor\/11.7.598","article-title":"A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations","volume":"11","author":"Brooks","year":"2001","journal-title":"Cereb. Cortex"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00004728-200209000-00026","article-title":"Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5-year-old child with developmental disorder: effects of dietary supplementation","volume":"26","author":"Cecil","year":"2002","journal-title":"J. Comput. Assist Tomogr."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.11.003_bib8","first-page":"804","article-title":"Fat in the cerebral falx","volume":"63","author":"Chen","year":"2000","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.11.003_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0730-725X(02)00512-X","article-title":"Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology","volume":"20","author":"Cheng","year":"2002","journal-title":"Magn. Reson Imaging"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neubiorev.2019.01.003","article-title":"Neurochemical changes in the aging brain: a systematic review","volume":"98","author":"Cleeland","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib11","unstructured":"Deelchand, D. 2016. MRspa: Magnetic Resonance signal processing and analysis. Minneapolis; Minnesota, U.S.A: \u3008https:\/\/www.cmrr.umn.edu\/downloads\/mrspa\/\u3009."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib12","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/mrm.25295","article-title":"Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T","volume":"73","author":"Deelchand","year":"2015","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib13","article-title":"Across-vendor standardization of semi-LASER for single-voxel MRS at 3T","author":"Deelchand","year":"2019","journal-title":"NMR Biomed."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.11.003_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/mrm.23080","article-title":"Measurement of transverse relaxation times of J-coupled metabolites in the human visual cortex at 4 T","volume":"67","author":"Deelchand","year":"2012","journal-title":"Magn. Reson. Med."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mrm.26788","article-title":"Improved localization, spectral quality, and repeatability with advanced MRS methodology in the clinical setting","volume":"79","author":"Deelchand","year":"2018","journal-title":"Magn. Reson Med"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuroimage.2016.05.014","article-title":"Physiological neuronal decline in healthy aging human brain \u2014 An in vivo study with MRI and short echo-time whole-brain 1H MR spectroscopic imaging","volume":"137","author":"Ding","year":"2016","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.11.003_bib17","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/brain\/awf226","article-title":"Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer\u2019s disease","volume":"125","author":"Dixon","year":"2002","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13195-020-00595-5","article-title":"Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging","volume":"12","author":"Doecke","year":"2020","journal-title":"Alzheimers Res Ther."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.11.003_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.2002.01041.x","article-title":"Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance","volume":"82","author":"Fisher","year":"2002","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib21","article-title":"Plasma p-tau181\/A\u03b2(1-42) ratio predicts A\u03b2-PET status and correlates with CSF-p-tau181\/A\u03b2(1-42) and future cognitive decline. Alzheimers Dement (Amst)","volume":"14","author":"Fowler","year":"2022"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119740","article-title":"Neurometabolic timecourse of healthy aging","volume":"264","author":"Gong","year":"2022","journal-title":"NeuroImage"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.11.003_bib23","doi-asserted-by":"crossref","first-page":"8684","DOI":"10.1002\/alz.14318","article-title":"Plasma p-tau181 and GFAP reflect 7T MR-derived changes in Alzheimer's disease: a longitudinal study of structural and functional MRI and MRS","volume":"20","author":"G\u00f6schel","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2023.115227","article-title":"Meta-analysis and open-source database for in vivo brain Magnetic Resonance spectroscopy in health and disease","volume":"676","author":"Gudmundson","year":"2023","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2021.09.016","article-title":"Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults","volume":"109","author":"Hone-Blanchet","year":"2022","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.11.003_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/a0020761","article-title":"A general approach to causal mediation analysis","volume":"15","author":"Imai","year":"2010","journal-title":"Psychol. Methods"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib27","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/awad042","article-title":"Predicting amyloid PET and tau PET stages with plasma biomarkers","volume":"146","author":"Jack","year":"2023","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.11.003_bib28","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/brain\/awaa248","article-title":"Predicting future rates of tau accumulation on PET","volume":"143","author":"Jack","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib29","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","author":"Jack Jr","year":"2024","journal-title":"Alzheimer's. Dement. N.\/a(N.\/a) 127"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib30","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/alz.13651","article-title":"Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals","volume":"20","author":"Jack Jr","year":"2024","journal-title":"Alzheimer's. Dement."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14405","article-title":"Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset","volume":"21","author":"Joynes","year":"2025","journal-title":"Alzheimer's. Dement."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.11.003_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.55.2.210","article-title":"Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study","volume":"55","author":"Kantarci","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1148\/radiol.2481071590","article-title":"Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements","volume":"248","author":"Kantarci","year":"2008","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.11.003_bib35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.0b013e31822dc7e1","article-title":"Magnetic resonance spectroscopy, \u03b2-amyloid load, and cognition in a population-based sample of cognitively normal older adults","volume":"77","author":"Kantarci","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.11.003_bib36","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/01.WNL.0000141849.21256.AC","article-title":"1H MR spectroscopy in common dementias","volume":"63","author":"Kantarci","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.11.003_bib37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archneur.65.12.1621","article-title":"Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes","volume":"65","author":"Kantarci","year":"2008","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.11.003_bib38","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.neurobiolaging.2006.06.018","article-title":"Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease","volume":"28","author":"Kantarci","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neurobiolaging.2021.12.010","article-title":"1 H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults","volume":"112","author":"Kara","year":"2022","journal-title":"Neurobiol. Aging"},{"issue":"17","key":"10.1016\/j.neurobiolaging.2025.11.003_bib40","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.3390\/ijms26178656","article-title":"Decoding thalamic glial interplay in multiple sclerosis through proton magnetic resonance spectroscopy and positron emission tomography","volume":"26","author":"Kara","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero Rodriguez","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.11.003_bib42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jama.2021.14075","article-title":"A guideline for reporting mediation analyses of randomized trials and observational studies: The AGReMA statement","volume":"326","author":"Lee","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4484","article-title":"Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): experts' consensus recommendations","volume":"34","author":"Lin","year":"2021","journal-title":"NMR Biomed."},{"issue":"42","key":"10.1016\/j.neurobiolaging.2025.11.003_bib44","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1523\/JNEUROSCI.2883-19.2020","article-title":"Regional myo-inositol, creatine, and choline levels are higher at older age and scale negatively with visuospatial working memory: a cross-sectional proton MR spectroscopy Study at 7 Tesla on Normal Cognitive Ageing","volume":"40","author":"Lind","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fnagi.2019.00222","article-title":"Age-dependent relationship between plasma A\u03b240 and A\u03b242 and total Tau levels in cognitively normal subjects","volume":"11","author":"Lue","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuroscience.2017.04.035","article-title":"Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using 1H magnetic resonance spectroscopy at 7 T","volume":"354","author":"Marja\u0144ska","year":"2017","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13195-023-01319-1","article-title":"Accuracy of plasma A\u03b240, A\u03b242, and p-tau181 to detect CSF Alzheimer's pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform","volume":"15","author":"Mart\u00ednez-Dubarbie","year":"2023","journal-title":"Alzheimers Res Ther."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.11.003_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4896","article-title":"MRS in neurodegenerative dementias, prodromal syndromes and at-risk states: A systematic review of the literature","volume":"36","author":"McKiernan","year":"2023","journal-title":"NMR Biomed."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.11.003_bib49","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat. Med"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.11.003_bib50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.11.003_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.11.003_bib52","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/acn3.530","article-title":"Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain","volume":"5","author":"Mullins","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"49","key":"10.1016\/j.neurobiolaging.2025.11.003_bib54","doi-asserted-by":"crossref","first-page":"16247","DOI":"10.1523\/JNEUROSCI.2027-14.2014","article-title":"Early Alzheimer's disease neuropathology detected by proton MR spectroscopy","volume":"34","author":"Murray","year":"2014","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4257","article-title":"Preprocessing, analysis and quantification in single-voxel magnetic resonance spectroscopy: experts' consensus recommendations","volume":"34","author":"Near","year":"2021","journal-title":"NMR Biomed."},{"issue":"13","key":"10.1016\/j.neurobiolaging.2025.11.003_bib56","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.0000000000004421","article-title":"1)H-MRS metabolites and rate of \u03b2-amyloid accumulation on serial PET in clinically normal adults","volume":"89","author":"Nedelska","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib57","article-title":"Myo-inositol and total NAA in the hippocampus are linked to CSF tau pathology in cognitively normal older adults","author":"Noche","year":"2024","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib58","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.13130531","article-title":"Clinical proton MR spectroscopy in central nervous system disorders","volume":"270","author":"Oz","year":"2014","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4236","article-title":"Advanced single voxel 1H magnetic resonance spectroscopy techniques in humans: experts' consensus recommendations","volume":"34","author":"\u00d6z","year":"2021","journal-title":"NMR Biomed."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.11.003_bib60","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma Phospho-tau217 for Alzheimer Disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib61","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/mrm.27203","article-title":"AutoVOI: real-time automatic prescription of volume-of-interest for single voxel spectroscopy","volume":"80","author":"Park","year":"2018","journal-title":"Magn. Reson. Med."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern Med"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.11.003_bib63","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1212\/WNL.0b013e3181f11d85","article-title":"Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging","volume":"75","author":"Petersen","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib64","article-title":"Longitudinal CSF Alzheimer's disease biomarker changes from middle age to late adulthood","volume":"14","author":"Pettigrew","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2007-973571","article-title":"Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy","volume":"29","author":"Pouwels","year":"1998","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.11.003_bib66","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson Med."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","article-title":"A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra","volume":"39","author":"Rae","year":"2014","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s41983-023-00649-z","article-title":"Metabolite changes in the posterior cingulate cortex could be a signature for early detection of Alzheimer\u2019s disease: a systematic review and meta-analysis study based on 1H NMR","volume":"59","author":"Rahim","year":"2023","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/02841850903476564","article-title":"Metabolite concentrations in supraventricular white matter from teenage to early old age: a short echo time 1h magnetic resonance spectroscopy (MRS) study","volume":"51","author":"Raininko","year":"2010","journal-title":"Acta Radiol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib70","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.ejrad.2011.01.106","article-title":"Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study","volume":"81","author":"Reyngoudt","year":"2012","journal-title":"Eur. J. Radio."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac135","article-title":"Astrocytic function is associated with both amyloid-\u03b2 and tau pathology in non-demented APOE \u03f54 carriers","volume":"4","author":"Spotorno","year":"2022","journal-title":"Brain Commun."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.11.003_bib73","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.11.003_bib74","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/archneur.60.12.1777","article-title":"Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment","volume":"60","author":"Tang-Wai","year":"2003","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.11.003_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhae046","article-title":"The developmental trajectory of 1H-MRS brain metabolites from childhood to adulthood","volume":"34","author":"Thomson","year":"2024","journal-title":"Cereb. Cortex"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v059.i05","article-title":"mediation: R Package for Causal Mediation Analysis","volume":"59","author":"Tingley","year":"2014","journal-title":"J. Stat. Softw."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.11.003_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14442","article-title":"Plasma A\u03b2(42)\/A\u03b2(40) is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum","volume":"21","author":"Trelle","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"19","key":"10.1016\/j.neurobiolaging.2025.11.003_bib78","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1212\/WNL.0000000000002672","article-title":"Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease","volume":"86","author":"Voevodskaya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","author":"Vogel","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.11.003_bib80","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3233\/JAD-170450","article-title":"Decreased N-Acetyl Aspartate\/Myo-Inositol ratio in the posterior cingulate cortex shown by magnetic resonance spectroscopy may be one of the risk markers of preclinical Alzheimer's disease: a 7-year follow-up study","volume":"60","author":"Waragai","year":"2017","journal-title":"J. Alzheimer's. Dis."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.11.003_bib81","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-2006-955968","article-title":"Methylsulfonylmethane (MSM) ingestion causes a significant resonance in proton magnetic resonance spectra of brain and cerebrospinal fluid","volume":"37","author":"Willemsen","year":"2006","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neurobiolaging.2025.11.003_bib82","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1202","article-title":"APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders","volume":"3","author":"Yin","year":"2015","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.11.003_bib83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/jamaneurol.2018.3057","article-title":"Association of bilateral salpingo-oophorectomy before menopause onset with medial temporal lobe neurodegeneration","volume":"76","author":"Zeydan","year":"2019","journal-title":"JAMA Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:29:49Z","timestamp":1773815389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":83,"alternative-id":["S0197458025001915"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.11.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1H-MR spectroscopy biomarkers are associated with plasma-derived biomarkers of amyloid-\u03b2 and tau in the early phase of AD continuum","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}